statistiche ricercatore

Continente	#
NA - Nord America	1.233
EU - Europa	721
AS - Asia	544
SA - Sud America	47
Continente sconosciuto - Info sul continente non disponibili	46
AF - Africa	36
OC - Oceania	2
Totale	2.629

Nazione	#
US - Stati Uniti d'America	1.214
CN - Cina	218
RU - Federazione Russa	213
SG - Singapore	164
GB - Regno Unito	114
DK - Danimarca	72
IT - Italia	66
DE - Germania	65
VN - Vietnam	59
SE - Svezia	48
BR - Brasile	36
FR - Francia	33
IN - India	21
FI - Finlandia	19
JP - Giappone	17
KR - Corea	15
HK - Hong Kong	14
IE - Irlanda	13
BE - Belgio	12
SN - Senegal	12
CI - Costa d'Avorio	11
CZ - Repubblica Ceca	9
CA - Canada	8
PL - Polonia	8
UA - Ucraina	8
AL - Albania	7
MX - Messico	7
ES - Italia	6
LT - Lituania	6
NL - Olanda	6
BD - Bangladesh	5
MA - Marocco	5
TR - Turchia	5
MY - Malesia	4
AR - Argentina	3
AT - Austria	3
EC - Ecuador	3
HR - Croazia	3
ID - Indonesia	3
TN - Tunisia	3
AU - Australia	2
CL - Cile	2
CO - Colombia	2
GR - Grecia	2
IQ - Iraq	2
KE - Kenya	2
KH - Cambogia	2
LV - Lettonia	2
PK - Pakistan	2
RO - Romania	2
RS - Serbia	2
SA - Arabia Saudita	2
TH - Thailandia	2
AZ - Azerbaigian	1
BG - Bulgaria	1
CR - Costa Rica	1
CY - Cipro	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
IR - Iran	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
MW - Malawi	1
NO - Norvegia	1
NP - Nepal	1
PA - Panama	1
PH - Filippine	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UZ - Uzbekistan	1
VE - Venezuela	1
ZA - Sudafrica	1
Totale	2.583

Nome	#
Modulation of 17β-Estradiol Signaling on Cellular Proliferation by Caveolin-2.	329
Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation	313
Emetine induces estrogen receptor alpha degradation and prevents 17β-estradiol-induced breast cancer cell proliferation	306
A high throughput method to study the physiology of E2:ERα signaling in breast cancer cells.	271
A functional drug re-purposing screening identifies carfilzomib as a drug preventing 17β-estradiol: ERα signaling and cell proliferation in breast cancer cells.	240
In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells.	228
Ouabain and Digoxin Activate the Proteasome and the Degradation of the ERalpha in Cells Modeling Primary and Metastatic Breast Cancer	216
Strategies to degrade estrogen receptor α in primary and ESR1 mutant-expressing metastatic breast cancer.	189
A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds Against ERalpha Expressing Breast Cancer Cells	183
Real-time measurement of E2: ERα transcriptional activity in living cells.	179
The extra-nuclear interactome of the estrogen receptors: implications for physiological functions	175
Totale	2.629

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	108	0	0	0	5	20	5	18	9	14	3	12	22
2022/2023	251	19	44	23	44	19	43	0	18	24	2	13	2
2023/2024	163	4	4	6	19	10	25	22	21	3	7	15	27
2024/2025	391	4	9	28	7	5	15	170	66	20	23	22	22
2025/2026	656	68	59	47	87	79	39	124	17	66	51	12	7
2026/2027	68	6	13	41	8	0	0	0	0	0	0	0	0
Totale													2.629

Benvenuti nell'Anagrafe della Ricerca d'Ateneo